Psychosocial factors facilitating use of cognitive enhancing drugs in education: a qualitative investigation of moral disengagement and associated processes

References

• Bandura, A. (1991). Social cognitive theory of moral thought and action. Handbook of Moral Behavior and Development, 1, 45–103.
   Google Scholar
• Bandura, A. (2002). Selective moral disengagement in the exercise of moral agency. Journal of Moral Education, 31, 101–119. doi: 10.1080/0305724022014322
   Web of Science ®Google Scholar
• Bandura, A., Barbaranelli, C., Caprara, G.V., & Pastorelli, C. (1996). Mechanisms of moral disengagement in the exercise of moral agency. Journal of Personality and Social Psychology, 71, 364. doi: 10.1037//0022-3514.71.2.364
   Web of Science ®Google Scholar
• Bell, S., Partridge, B., Lucke, J., & Hall, W. (2013). Australian university students’ attitudes towards the acceptability and regulation of pharmaceuticals to improve academic performance. Neuroethics, 6, 197–205. doi: 10.1007/s12152-012-9153-9
   Web of Science ®Google Scholar
• Boardley, I.D., & Grix, J. (2014). Doping in bodybuilders: A qualitative investigation of facilitative psychosocial processes. Qualitative Research in Sport, Exercise and Health, 6, 422–439. doi: 10.1080/2159676X.2013.766809
   Google Scholar
• Boardley, I.D., Grix, J., & Dewar, A.J. (2014). Moral disengagement and associated processes in performance-enhancing drug use: A national qualitative investigation. Journal of Sports Sciences, 32, 836–844. doi: 10.1080/02640414.2013.862842
   PubMed Web of Science ®Google Scholar
• Boardley, I.D., Grix, J., & Harkin, J. (2015). Doping in team and individual sports: A qualitative investigation of moral disengagement and associated processes. Qualitative Research in Sport, Exercise and Health, 7, 698–717. doi: 10.1080/2159676X.2014.992039
   Web of Science ®Google Scholar
• Boardley, I.D., Smith, A.L., Mills, J.P., Grix, J., & Wynne, C. (2017). Empathic and self-regulatory processes governing doping behavior. Frontiers in Psychology, 8, 1495. doi: 10.3389/fpsyg.2017.01495
   PubMed Web of Science ®Google Scholar
• Brustad, R. (2008). Qualitative research approaches. Advances in Sport Psychology, 3, 31–44.
   Google Scholar
• Cakic, V. (2009). Smart drugs for cognitive enhancement: Ethical and pragmatic considerations in the era of cosmetic neurology. Journal of Medical Ethics, 35, 611–615. doi: 10.1136/jme.2009.030882
   PubMed Web of Science ®Google Scholar
• De Jongh, R., Bolt, I., Schermer, M., & Olivier, B. (2008). Botox for the brain: Enhancement of cognition, mood and pro-social behavior and blunting of unwanted memories. Neuroscience & Biobehavioral Reviews, 32, 760–776. doi: 10.1016/j.neubiorev.2007.12.001
   PubMed Web of Science ®Google Scholar
• De Wever, B., Schellens, T., Valcke, M., & Van Keer, H. (2006). Content analysis schemes to analyze transcripts of online asynchronous discussion groups: A review. Computers & Education, 46, 6–28. doi: 10.1016/j.compedu.2005.04.005
   Web of Science ®Google Scholar
• Dietz, P., Striegel, H., Franke, A.G., Lieb, K., Simon, P., & Ulrich, R. (2013). Randomized response estimates for the 12-month prevalence of cognitive-enhancing drug use in university students. Pharmacotherapy, 33, 44–50. doi: 10.1002/phar.1166
   PubMed Web of Science ®Google Scholar
• Duke University. (2017). Student conduct and academic dishonesty. Retrieved from https://studentaffairs.duke.edu/node/2350
   Google Scholar
• Farah, M.J., Illes, J., Cook-Deegan, R., Gardner, H., Kandel, E., King, P., … Wolpe, P.R. (2004). Neurocognitive enhancement: What can we do and what should we do? Nature Reviews Neuroscience, 5, 421–425. doi: 10.1038/nrn1390
   PubMed Web of Science ®Google Scholar
• Finger, G., Silva, E.R.D., & Falavigna, A. (2013). Use of methylphenidate among medical students: A systematic review. Revista da Associação Médica Brasileira, 59, 285–289. doi: 10.1016/j.ramb.2012.10.007
   PubMed Web of Science ®Google Scholar
• Food and Drug Administration. (2017). Finding and learning about side effects. Retrieved from https://www.fda.gov/Drugs/ResourcesForYou/Consumers/ucm196029.htm
   Google Scholar
• Forlini, C., & Racine, E. (2012). Added value(s) to the cog- nitive enhancement debate: Are we sidestepping values in academic discourse and professional policies? AJOB Primary Research, 3, 33–47. doi: 10.1080/21507716.2011.645116
   Google Scholar
• Forlini, C., Schildmann, J., Roser, P., Beranek, R., & Vollmann, J. (2015). Knowledge, experiences and views of German university students toward neuroenhancement: An empirical-ethical analysis. Neuroethics, 8, 83–92. doi: 10.1007/s12152-014-9218-z
   Web of Science ®Google Scholar
• Franke, A.G., Bagusat, C., Rust, S., Engel, A., & Lieb, K. (2014). Substances used and prevalence rates of pharmacological cognitive enhancement among healthy subjects. European Archives of Psychiatry and Clinical Neuroscience, 264, 83–90. doi: 10.1007/s00406-014-0537-1
   PubMed Web of Science ®Google Scholar
• Franke, A.G., Bonertz, C., Christmann, M., Huss, M., Fellgiebel, A., Hildt, E., & Lieb, K. (2011). Non-medical use of prescription stimulants and illicit use of stimulants for cognitive enhancement in pupils and students in Germany. Pharmacopsychiatry, 44, 60. doi: 10.1055/s-0030-1268417
   PubMed Web of Science ®Google Scholar
• Fullerton, A. (2017, March 17). Oxford University Student Union introduces ‘smart drug’ workshops for students. The Telegraph. Retrieved from https://www.telegraph.co.uk/education/2017/03/06/oxford-university-student-union-introduces-smart-drug-workshops/
   Google Scholar
• Gahr, M., Freudenmann, R.W., Hiemke, C., Kölle, M.A., & Schönfeldt-Lecuona, C. (2014). Abuse of methylphenidate in Germany: Data from spontaneous reports of adverse drug reactions. Psychiatry Research, 215, 252–254. doi: 10.1016/j.psychres.2013.11.008
   PubMed Web of Science ®Google Scholar
• Harris, J. (2009). Is it acceptable for people to take methylphenidate to enhance performance? Yes. BMJ, 338, b1955. doi: 10.1136/bmj.b1955
   PubMedGoogle Scholar
• Hsieh, H.F., & Shannon, S.E. (2005). Three approaches to qualitative content analysis. Qualitative Health Research, 15, 1277–1288. doi: 10.1177/1049732305276687
   PubMed Web of Science ®Google Scholar
• Hübner, M. (2012). Do tuition fees affect enrollment behavior? Evidence from a ‘natural experiment’in Germany. Economics of Education Review, 31, 949–960. doi: 10.1016/j.econedurev.2012.06.006
   Web of Science ®Google Scholar
• Hysek, C.M., Simmler, L.D., Schillinger, N., Meyer, N., Schmid, Y., Donzelli, M., … Liechti, M.E. (2014). Pharmacokinetic and pharmacodynamic effects of methylphenidate and MDMA administered alone or in combination. International Journal of Neuropsychopharmacology, 17, 371–381. doi: 10.1017/S1461145713001132
   PubMed Web of Science ®Google Scholar
• Kirby, K., Moran, A., & Guerin, S. (2011). A qualitative analysis of the experiences of elite athletes who have admitted to doping for performance enhancement. International Journal of Sport Policy and Politics, 3, 205–224. doi: 10.1080/19406940.2011.577081
   Google Scholar
• McGannon, K.R., & Smith, B. (2015). Centralizing culture in cultural sport psychology research: The potential of narrative inquiry and discursive psychology. Psychology of Sport and Exercise, 17, 79–87. doi: 10.1016/j.psychsport.2014.07.010
   Web of Science ®Google Scholar
• McVeigh, J., Evans-Brown, M., & Bellis, M. (2012). Human enhancement drugs and the pursuit of perfection. Adicciones, 24, 185. doi: 10.20882/adicciones.89
   PubMed Web of Science ®Google Scholar
• MHRA. (2013). Modafinil 200 mg tablets [online]. Retrieved from http://www.mhra.gov.uk/home/groups/par/documents/websiteresources/con273748.pdf [Accessed 14 Feb, 2018]
   Google Scholar
• Miller, A.D., Murdock, T.B., & Grotewiel, M.M. (2017). Addressing academic dishonesty among the highest achievers. Theory into Practice, 56, 121–128. doi: 10.1080/00405841.2017.1283574
   Web of Science ®Google Scholar
• Misuse of Drugs Act. (1971). Retrieved from https://www.legislation.gov.uk/ukpga/1971/38/contents
   Google Scholar
• Møldrup, C., & Rie Hansen, R. (2006). Public acceptance of drug use for non-disease conditions. Current Medical Research and Opinion, 22, 775–780. doi: 10.1185/030079906X100258
   PubMed Web of Science ®Google Scholar
• Morton, W.A., & Stock, G.G. (2000). Methylphenidate abuse and psychiatric side effects. Primary Care Companion to the Journal of Clinical Psychiatry, 02, 159–164. doi: 10.4088/PCC.v02n0502
   Google Scholar
• Ott, R., & Biller-Andorno, N. (2014). Neuroenhancement among Swiss students–a comparison of users and non-users. Pharmacopsychiatry, 47, 22–28. doi: 10.1055/s-0033-1358682
   PubMed Web of Science ®Google Scholar
• Partridge, B.J., Bell, S.K., Lucke, J.C., Yeates, S., & Hall, W.D. (2011). Smart drugs “as common as coffee”: Media hype about neuroenhancement. PLoS One, 6, e28416. doi: 10.1371/journal.pone.0028416
   PubMed Web of Science ®Google Scholar
• Partridge, B., Lucke, J., & Hall, W. (2012). A comparison of attitudes toward cognitive enhancement and legalized doping in sport in a community sample of Australian adults. AJOB Primary Research, 3, 81–86. doi: 10.1080/21507716.2012.720639
   Google Scholar
• Passini, S. (2012). The delinquency-drug relationship: The influence of social reputation and moral disengagement. Addictive behaviors, 37, 577–579. doi: 10.1016/j.addbeh.2012.01.012
   PubMed Web of Science ®Google Scholar
• Petróczi, A., & Aidman, E. (2008). Psychological drivers in doping: The life-cycle model of performance enhancement. Substance Abuse Treatment, Prevention, and Policy, 3, 7. doi: 10.1186/1747-597X-3-7
   PubMed Web of Science ®Google Scholar
• Petróczi, A., Nepusz, T., Cross, P., Taft, H., Shah, S., Deshmukh, N., … Naughton DP. (2011). New non-randomised model to assess the prevalence of discriminating behaviour: A pilot study on mephedrone. Substance Abuse Treatment, Prevention, and Policy, 6, 20. doi: 10.1186/1747-597X-6-20
   PubMed Web of Science ®Google Scholar
• Rambhade, S., Chakarborty, A., Shrivastava, A., Patil, U.K., & Rambhade, A. (2012). A survey on polypharmacy and use of inappropriate medications. Toxicology International, 19, 68. doi: 10.4103/0971-6580.94506
   PubMedGoogle Scholar
• Ross, S., Cleland, J., & Macleod, M.J. (2006). Stress, debt and undergraduate medical student performance. Medical Education, 40, 584–589. doi: 10.1111/j.1365-2929.2006.02448.x
   PubMed Web of Science ®Google Scholar
• Sahakian, B.J., & Morein-Zamir, S. (2011). Neuroethical issues in cognitive enhancement. Journal of Psychopharmacology, 25, 197–204. doi: 10.1177/0269881109106926
   PubMed Web of Science ®Google Scholar
• Schermer, M. (2008). On the argument that enhancement is “cheating”. Journal of Medical Ethics, 34, 85–88. doi: 10.1136/jme.2006.019646
   PubMed Web of Science ®Google Scholar
• Singh, I., Bard, I., & Jackson, J. (2014). Robust resilience and substantial interest: A survey of pharmacological cognitive enhancement among university students in the UK and Ireland. PLoS One, 9, e105969. doi: 10.1371/journal.pone.0105969
   PubMed Web of Science ®Google Scholar
• Smith, M.E., & Farah, M.J. (2011). Are prescription stimulants “smart pills”? The epidemiology and cognitive neuroscience of prescription stimulant use by normal healthy individuals. Psychological Bulletin, 137, 717. doi: 10.1037/a0023825
   PubMed Web of Science ®Google Scholar
• Steward, A., & Pickersgill, M. (2019). Developing expertise, customising sleep, enhancing study practices: Exploring the legitimisation of modafinil use within the accounts of UK undergraduate students. Drugs: Education, Prevention and Policy, 1–9. doi: 10.1080/09687637.2018.1555231
   Google Scholar
• University of Birmingham. (2013). Drugs and alcohol policy. Retrieved from https://www.birmingham.ac.uk/Documents/university/legal/14-15/drug-alcohol.pdf
   Google Scholar
• Vargo, E.J., James, R.A., Agyeman, K., MacPhee, T., McIntyre, R., Ronca, F., & Petróczi, A. (2014). Perceptions of assisted cognitive and sport performance enhancement among university students in England. Performance Enhancement & Health, 3, 66–77. doi: 10.1016/j.peh.2015.02.001
   Google Scholar
• Vargo, E.J., & Petróczi, A. (2016). “It was me on a good day”: Exploring the smart drug use phenomenon in England. Frontiers in Psychology, 7, 779. doi: 10.3389/fpsyg.2016.00779
   PubMed Web of Science ®Google Scholar
• Vetter, V.L., Elia, J., Erickson, C., Berger, S., Blum, N., Uzark, K., & Webb, C.L. (2008). Cardiovascular monitoring of children and adolescents with heart disease receiving stimulant drugs. A scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young Congenital Cardiac Defects Committee and the Council on Cardiovascular Nursing. Circulation, 117, 2407–2423. doi: 10.1161/CIRCULATIONAHA.107.189473
   Web of Science ®Google Scholar
• Vrecko, S. (2013). Just how cognitive is “cognitive enhancement”? On the significance of emotions in university students’ experiences with study drugs. AJOB Neuroscience, 4, 4–12. doi: 10.1080/21507740.2012.740141
   PubMedGoogle Scholar
• Whetstine, L.M. (2015). Cognitive enhancement: Treating or cheating? Seminars in Pediatric Neurology 22, 172–176. doi: 10.1016/j.spen.2015.05.003
   Google Scholar
• Wilens, T.E., Adler, L.A., Adams, J., Sgambati, S., Rotrosen, J., Sawtelle, R., … Fusillo, S. (2008). Misuse and diversion of stimulants prescribed for ADHD: A systematic review of the literature. Journal of the American Academy of Child & Adolescent Psychiatry, 47, 21–31. doi: 10.1097/chi.0b013e31815a56f1
   PubMed Web of Science ®Google Scholar
• Wingrove, T., Korpasa, A.L., & Weisz, V. (2011). Why were millions of people not obeying the law? Motivational influences on non-compliance with the law in the case of music piracy. Psychology, Crime & Law, 17, 261–276. doi: 10.1080/10683160903179526
   Web of Science ®Google Scholar
• Wolff, W., & Brand, R. (2013). Subjective stressors in school and their relation to neuroenhancement: A behavioral perspective on students’ everyday life “doping”. Substance Abuse Treatment, Prevention, and Policy, 8, 23. doi: 10.1186/1747-597X-8-23
   PubMed Web of Science ®Google Scholar